Table 4 Association of miR-34a and miR-206 expression with clinicopathological features
From: MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
Variables | No. of cases | No. of expression of miR-34a | No. of expression of miR-206 | miR-34a (P) | miR-206 (P) | ||
|---|---|---|---|---|---|---|---|
Low = 21 | High = 20 | Low = 23 | High = 18 | ||||
Tumor size (cm) | |||||||
 >4 | 18 | 4 | 14 | 5 | 13 | 0.002 | 0.002 |
 ≤4 | 23 | 17 | 6 | 18 | 5 | ||
Histological grades | |||||||
 Well differentiated | 4 | 0 | 4 | 0 | 4 | 0.029 | 0.023 |
 Moderate differentiated | 34 | 18 | 16 | 20 | 14 | ||
 Poorly differentiated | 3 | 3 | 0 | 3 | 0 | ||
FIGO stage | |||||||
 Ib–IIa | 25 | 24 | 1 | 7 | 18 | 0.000 | 0.000 |
 IIb–IIIa | 12 | 6 | 6 | 12 | 0 | ||
 IIIb above | 4 | 0 | 4 | 4 | 0 | ||
Lymph node metasis | |||||||
 Yes | 17 | 15 | 2 | 17 | 0 | 0.000 | 0.001 |
 No | 24 | 6 | 18 | 6 | 18 | ||